In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against other best affordable stocks under $20 to buy. On May 6, Paul Tudor Jones ...

In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against other small-cap healthcare stocks hedge funds are buying. The U.S ...

JERUSALEM, May 7 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab reported a larger than expected rise in first-quarter profit, helped by strong sales gains for a trio of its ...

Before you buy stock in Teva Pharmaceutical Industries, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now ...

In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against other Wednesday’s best-performing stocks. The stock market rebounded on ...

Fintel reports that on May 12, 2025, JP Morgan upgraded their outlook for Teva Pharmaceutical Industries Limited - Depositary Receipt () (NYSE:TEVA) from Neutral to Overweight. As of May 7 ...

Three biosimilar BLAs from Teva-Alvotech are under FDA review, with approvals expected in Q4 2025. Get our list of 10 overlooked stocks—including one paying a 9% dividend—before Wall Street ...

Austedo U.S. sales rose 40% to $396 million in Q1 2025, with global sales up 39% in local currency. Q1 adjusted EPS was $0.52, beating $0.48 estimates; Teva raised 2025 EPS outlook to $2.45–$2.65.

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA. Teva Pharmaceutical Industries ...